Vbi Vaccines Stock Probability Of Bankruptcy
| VBIV Stock | USD 0.63 0.02 3.28% |
VBI | Probability Of Bankruptcy |
VBI Vaccines Company odds of financial turmoil Analysis
VBI Vaccines' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current VBI Vaccines Probability Of Bankruptcy | Over 79% |
Most of VBI Vaccines' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VBI Vaccines is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of VBI Vaccines probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting VBI Vaccines odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of VBI Vaccines financial health.
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.79) | Revenue Per Share 0.689 | Quarterly Revenue Growth 19.896 | Return On Assets (0.29) | Return On Equity (2.20) |
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
VBI Probability Of Bankruptcy Driver Correlations
Understanding the fundamental principles of building solid financial models for VBI Vaccines is extremely important. It helps to project a fair market value of VBI Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since VBI Vaccines' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of VBI Vaccines' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of VBI Vaccines' interrelated accounts and indicators.
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, VBI Vaccines has a Probability Of Bankruptcy of 79%. This is 82.49% higher than that of the Biotechnology sector and 44.06% higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 98.34% lower than that of the firm.
VBI Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VBI Vaccines' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VBI Vaccines could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics of similar companies.VBI Vaccines is currently under evaluation in probability of bankruptcy category among related companies.
VBI Vaccines Main Bankruptcy Drivers
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Asset Turnover | 0.0182 | 0.005068 | 0.003001 | 0.006977 | 0.0998 | 0.1 | |
| Gross Profit Margin | (2.56) | (7.64) | (16.07) | (9.42) | (0.44) | (0.46) | |
| Net Debt | (29.4M) | (92.9M) | (89.9M) | (10.4M) | 29.4M | 30.8M | |
| Total Current Liabilities | 29.8M | 17.3M | 32.6M | 36.9M | 75.7M | 79.5M | |
| Non Current Liabilities Total | 4.2M | 20.3M | 33.8M | 54.0M | 3.7M | 3.5M | |
| Total Assets | 122.2M | 209.4M | 210.3M | 155.1M | 87.0M | 73.5M | |
| Total Current Assets | 47.0M | 132.0M | 130.3M | 77.7M | 36.2M | 33.0M | |
| Total Cash From Operating Activities | (48.7M) | (47.1M) | (39.9M) | (73.7M) | (60.9M) | (57.8M) |
VBI Fundamentals
| Return On Equity | -2.2 | ||||
| Return On Asset | -0.29 | ||||
| Operating Margin | (0.98) % | ||||
| Current Valuation | 31 M | ||||
| Shares Outstanding | 28.43 M | ||||
| Shares Owned By Insiders | 7.69 % | ||||
| Shares Owned By Institutions | 11.84 % | ||||
| Number Of Shares Shorted | 289.12 K | ||||
| Price To Earning | (3.79) X | ||||
| Price To Book | 0.82 X | ||||
| Price To Sales | 2.02 X | ||||
| Revenue | 8.68 M | ||||
| Gross Profit | (10.19 M) | ||||
| EBITDA | (79.91 M) | ||||
| Net Income | (92.84 M) | ||||
| Cash And Equivalents | 82.41 M | ||||
| Cash Per Share | 0.32 X | ||||
| Total Debt | 53.04 M | ||||
| Debt To Equity | 0.32 % | ||||
| Current Ratio | 2.29 X | ||||
| Book Value Per Share | 0.85 X | ||||
| Cash Flow From Operations | (60.88 M) | ||||
| Short Ratio | 3.78 X | ||||
| Earnings Per Share | (9.79) X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 190 | ||||
| Beta | 1.92 | ||||
| Market Capitalization | 17.06 M | ||||
| Total Asset | 86.95 M | ||||
| Retained Earnings | (582.45 M) | ||||
| Working Capital | (39.51 M) | ||||
| Current Asset | 7.89 M | ||||
| Current Liabilities | 3.03 M | ||||
| Net Asset | 86.95 M |
About VBI Vaccines Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VBI Vaccines's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VBI Vaccines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VBI Vaccines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VBI Vaccines in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VBI Vaccines' short interest history, or implied volatility extrapolated from VBI Vaccines options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports:Check out VBI Vaccines Piotroski F Score and VBI Vaccines Altman Z Score analysis. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for VBI Stock analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.79) | Revenue Per Share 0.689 | Quarterly Revenue Growth 19.896 | Return On Assets (0.29) | Return On Equity (2.20) |
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.